Pulmonary intravascular macrophages as proinflammatory cells in heaves, an asthma-like equine disease.
Heaves, an obstructive neutrophilic airway inflammation of horses, is triggered by dust components such as endotoxin and has similarities to human asthma. Pulmonary intravascular macrophages (PIMs) increase horses' sensitivity to endotoxin-induced lung inflammation; however, their role in an airborne pathology remains unknown. Therefore, we investigated the role of PIMs in the development of heaves in horses. Clinical and inflammatory responses were evaluated following induction of heaves by moldy hay exposure and PIM depletion with gadolinium chloride (GC). Mares (N = 9) were exposed to four treatments: alfalfa cubes (Cb), alfalfa cubes + GC (Cb-GC), moldy hay (MH), and moldy hay + GC (MH-GC). Clinical scores and neutrophil concentrations in bronchoalveolar lavage (BAL) fluid were higher when mares received MH compared with MH-GC. BAL cells from MH-GC-treated mares had significantly lower IL-8 and TLR4 mRNA expression compared with MH-treated mares. In vitro LPS challenge significantly increased IL-8 but not TLR4 mRNA expression in BAL cells recovered from horses fed with MH, but not from the MH-GC treatment. In summary, PIM depletion attenuated clinical scores, reduced the alveolar migration of neutrophils, and decreased the expression of proinflammatory molecules in BAL cells of heaves horses, suggesting a proinflammatory role of PIMs in the development of airborne pathology.
Department of Veterinary Biomedical Sciences, University of Saskatchewan, Saskatoon, Canada.
Karin
K
Aharonson-Raz
Katharina L
KL
Lohmann
Hugh G
HG
Townsend
Fernando
F
Marques
Baljit
B
Singh
D000402:Airway Obstruction / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D000818:Animals; D001249:Asthma / Q000188:drug therapy / Q000276:immunology* / Q000378:metabolism; D015153:Blotting, Western; D018893:Bronchoalveolar Lavage / Q000662:veterinary; D004391:Dust / Q000276:immunology; D004731:Endotoxins / Q000494:pharmacology; D005260:Female; D006734:Horse Diseases / Q000188:drug therapy / Q000276:immunology* / Q000378:metabolism; D006736:Horses; D006801:Humans; D016209:Interleukin-8 / Q000235:genetics / Q000378:metabolism; D008070:Lipopolysaccharides / Q000494:pharmacology; D016676:Macrophages, Alveolar / Q000187:drug effects / Q000276:immunology* / Q000378:metabolism; D009504:Neutrophils / Q000276:immunology / Q000378:metabolism; D011014:Pneumonia / Q000188:drug therapy / Q000276:immunology* / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics; D060888:Real-Time Polymerase Chain Reaction; D020133:Reverse Transcriptase Polymerase Chain Reaction
D004391:Dust; D004731:Endotoxins; D016209:Interleukin-8; D008070:Lipopolysaccharides; D012333:RNA, Messenger